About Innova SARS-CoV-2 Rapid Antigen Test

The Most Used Antigen Tests in The World. Fast, Accurate and Equitable.

Innova Medical Group is the world’s largest manufacturer of COVID tests. We’ve delivered over 500 million Innova SARS-CoV-2 rapid antigen test kits to over 20 countries.

How It Works

The Innova SARS-CoV-2 antigen test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers.

Rapid Antigen Testing Solution
Innova Features:
Innova Features

Currently producing in US and Asia with a capacity of

15 million kits per day

and ramping up to

50 million kits per day

by summer 2021.

Rapid Antigen Testing Solution
Rapid Antigen Testing Solution
Proven Efficacy

In the UK Porton Down study, the Innova antigen test had a sensitivity of 97.0% in detecting infectious patients when testing 323 COVID-19 positive patients, regardless of symptoms.

(viral load >= 100,000 copies/mL or Ct value <=25)

The Innova antigen test has a specificity of 99.9% to 99.97% from over 2.7 million tests.

Read Studies and Reports on Innova SARS-CoV-2 Rapid Antigen Tests

Test Procedure

01

Testing Process

02

Testing Process

03

Testing Process

04

Testing Process

05

Testing Process

06

Testing Process

07

Testing Process

Negative Result

One line next to C indicates the test is negative

Positive Result

Two line next to C and one next to T, even faint lines indicates the test is positive